Table 1.
Baseline Characteristics of CF-LVAD Patients with or without Aortic Root Thrombosis
| Variable | ART (n=21) | No ART (n=415) | p-value |
|---|---|---|---|
| Demographics | |||
| Age, years | 63.6(52.4–68.6) | 59.6(48.0–67.1) | 0.407 |
| Female gender | 2 (9.5%) | 92 (22.2%) | 0.274 |
| Race / Ethnicity | 0.873 | ||
| White | 10 (47.6%) | 233 (56.1%) | |
| Black | 7 (33.3%) | 114 (27.5%) | |
| Hispanic | 3 (14.3%) | 46(11.1%) | |
| Other | 1 (4.8%) | 22 (5.3%) | |
| BMI, kg/m2 | 25.3 (23.0–38.1) | 25.9(22.6–30.1) | 0.754 |
| BSA, m2 | 1.91 (1.76–2.02) | 1.95 (1.78–2.13) | 0.443 |
| Device Type | 0.849 | ||
| Heartmate II | 19 (90.5%) | 370 (89.2%) | |
| Heartware | 2 (9.5%) | 45 (10.8%) | |
| Etiology of HF | 0.282 | ||
| Ischemic | 7 (33.3%) | 188 (45.3%) | |
| Non-Ischemic | 14 (66.7%) | 227 (54.7%) | |
| Strategy | 0.021 | ||
| BTT | 7 (33.3%) | 250 (60.2%) | |
| DT | 14 (66.7%) | 165 (39.8%) | |
| Aortic Valve | 0.264 | ||
| Native | 15 (71.4%) | 328 (79.0%) | |
| Native, s/p repair with LVAD | 4(19.0%) | 75 (18.1%) | |
| Native, s/p bio-AVR with LVAD | 0 (0.0%) | 3 (0.7%) | |
| s/p bio-AVR (old) | 1 (4.8%) | 6(1.4%) | |
| s/p mechanical-AVR (old) | 1 (4.8%) | 3 (0.7%) | |
| WBC count | 8.3 (7.0–9.3) | 8.0(6.4–10.3) | 0.725 |
| Hemoglobin | 11.2(9.0–12.7) | 11.1 (9.6–12.6) | 0.936 |
| Platelet | 200(189–238) | 190(148–244) | 0.301 |
| Creatinine | 1.34(1.04– 1.50) | 1.34(1.00– 1.70) | 0.855 |
| Albumin | 3.4 (3.0–3.7) | 3.6 (3.2–4.0) | 0.140 |
| Bilirubin (total) | 1.0 (0.8 −2.1) | 1.0 (0.7–1.7) | 0.531 |
| LVAD Risk Scores | |||
| HMRS | 1.70(1.12–2.30) | 1.48 (1.01 – 1.98) | 0.245 |
| MELD-Xi | 14.7(12.6–17.9) | 14.2(11.5–17.4) | 0.709 |